"renal cancer" trang 8 - tải miễn phí từ tailieunhanh
Snail heterogeneity in clear cell renal cell carcinoma

Snail heterogeneity in clear cell renal cell carcinoma
8    58    1
Response to post-axitinib treatment in patients with metastatic renal cell carcinoma

Response to post-axitinib treatment in patients with metastatic renal cell carcinoma
7    52    1
A case study on the potential angiogenic effect of human chorionic gonadotropin hormone in rapid progression and spontaneous regression of metastatic renal cell carcinoma during pregnancy and after surgical abortion

A case study on the potential angiogenic effect of human chorionic gonadotropin hormone in rapid progression and spontaneous regression of metastatic renal cell carcinoma during pregnancy and after surgical abortion
7    87    1
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry

Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
11    45    1
GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: An intrinsic subcellular mechanism for resistance to mTORC1 inhibition

GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: An intrinsic subcellular mechanism for resistance to mTORC1 inhibition
12    42    1
Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma

Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma
9    47    1
CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma

CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma
12    62    1
A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine

A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine
7    46    1
The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma

The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
7    42    1
Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: Final results of a noninterventional study

Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: Final results of a noninterventional study
10    44    1
Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis

Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis
12    43    1
Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma
9    56    1
Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma

Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma
7    37    1
Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma

Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma
9    38    1
The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ

The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ
7    45    1
Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis

Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis
9    48    1
Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma

Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma
6    59    1
The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma

The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma
16    47    2
Standard b-value versus low b-value diffusion-weighted MRI in renal cell carcinoma: A systematic review and meta-analysis

Standard b-value versus low b-value diffusion-weighted MRI in renal cell carcinoma: A systematic review and meta-analysis
8    41    1
GPC3 reduces cell proliferation in renal carcinoma cell lines

GPC3 reduces cell proliferation in renal carcinoma cell lines
11    56    1